Please click on the link to see a list of melanoma journal articles that came across the MRV desk recently.
Archive | Melanoma News
Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of response
Given that objective responses in 30% to 50% of patients suffering from metastatic melanoma is mediated by adoptive cell transfer (ACT) of tumor-infiltrating lymphocytes (TIL), as per multiple, small phase 2 trials, so, researchers assessed long-term clinical outcomes, intent-to-treat analysis, predictors of response as well as toxicity profile in a large patient cohort.
Posted in Melanoma News, Publications, Scientific Publications
Association between immune-related adverse events and recurrence-free survival among patients with stage III melanoma randomized to receive pembrolizumab or placebo : A secondary analysis of a randomized clinical trial
In the present study, the researchers sought to explore the connection between immune-related adverse events and recurrence-free survival (RFS) in the double-blind EORTC 1325/KEYNOTE-054 clinical trial comparing pembrolizumab therapy and placebo for the treatment of individuals with high-risk stage III melanoma.
Posted in Melanoma News, Publications, Scientific Publications
Skin Cancer Test Reduces Need for Surgery
SkylineDx in collaboration with the Mayo Clinic published yesterday its first study describing a diagnostic test that could reduce up to 42% of surgical interventions used to diagnose patients with melanoma (skin cancer).
Posted in Melanoma News, Health Professionals, Of Interest
